Latest findings
MBS services via telehealth (phone and video conferencing) increased by 51% from Jun quarter to Sep quarter in 2021
The pandemic had minimal impact on total script volumes, with a 2% growth in the year ending Sep 2021 compared to 2020
Supply issues for arthritis medication tocilizumab didn't occur, with 2% growth in the Sep 2021 quarter compared to 2020
Jun to Sep quarters 2021, GP consults up 9% (suitability for COVID vaccine +194%, microbiology tests on referral +72%)
MBS services and benefits paid increased by 13% and 6% respectively in Sep quarter 2021 compared to Sep quarter 2020
Comparing the Sep quarter in 2021 to 2020, the medicine group with the largest script increase was anti-infectives (7%)